Background. The recently published histopathologic classification of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis might greatly aid in the prognostication of patients at the time of diagnosis. This study aims to re-evaluate the new classification for its prognostic capacity in an independent Chinese series. Methods. One hundred and twenty-one consecutive patients with ANCA-associated glomerulonephritis, diagnosed in our center from 1997 to 2010, were included in this retrospective study. The renal specimens were reviewed according to the proposed histopathologic classification. The predictive value of the classification for renal outcome and renal response to treatment was analyzed. Results. Thirty-three (27.3%), 24 (19.8%), 53 (43.8%) and 11 (9.1%) patients were classified as focal, mixed, crescentic and sclerotic ANCA-associated glomerulonephritis, respectively. The renal biopsy categories correlated with initial serum creatinine and the renal response to treatment (P < 0.001, P < 0.01, respectively). The probability of progressing to end-stage renal disease (ESRD) increased with ascending categories of focal, mixed, crescentic and sclerotic glomerulonephritis (P < 0.01). The patients with focal, mixed and crescentic ANCA-associated glomerulonephritis were all at decreased risk for developing ESRD compared with the patients with in the sclerotic category (P < 0.05). Conclusions. The proposed classification system was reevaluated for the first time in a relatively large and independent series of patients. This system reflects the severity of the initial renal impairment and can predict, at least to some extent, the renal response to treatment. More importantly, it can independently predict renal outcome, in particular development of ESRD.
Introduction
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes granulomatosis with polyangiitis (GPA, previously named Wegener's granulomatosis), microscopic polyangiitis (MPA), Churg-Strauss syndrome and renal-limited vasculitis (RLV). The kidney is one of the most common organs involved, usually manifesting as rapidly progressive glomerulonephritis. A number of clinicopathological studies analyzed the prognostic value of the renal biopsy in ANCA-associated glomerulonephritis. Factors such as the percentage of normal glomeruli and the percentage of sclerosed glomeruli in the initial renal biopsy as well as baseline renal function have been proven to be prognostic indicators of renal outcome [1] [2] [3] [4] [5] . However, no consensus existed regarding the pathological classification until, recently, a new histopathologic classification of ANCA-associated glomerulonephritis was proposed by an international working group of renal pathologists. This created a new method of prognostication of patients at the time of the diagnosis [6] . It was built around four general categories, i.e. focal, crescentic, sclerotic and mixed glomerulonephritis. A validation of this classification based on a total of 100 patients with at least 1 year of follow-up has also been performed [6] . The results showed that during follow-up, the phenotypical order of categories (focal, crescentic, mixed and sclerotic) corresponded to the severity of renal function loss [6] .
This new classification has shown its predictive value and reproducibility as a classification system. However, there are still some issues which need further investigation [6, 7] . Firstly, all patients were seen in European centers only. Secondly, patients for the validation study came from various centers where the system was applied in comparable but not exactly identical ways, as stated by Berden et al. [6] . Thirdly, it was proven that the proposed classification system was of prognostic value for 1-and 5-year renal outcomes [6] , but not for the renal response to treatment.
In the current study, 121 patients with ANCA-associated glomerulonephritis, diagnosed in a single center from 1997 to 2010, were analyzed to re-evaluate this classification for its predictive power with respect to renal outcome and response to treatment.
Materials and methods

Patients
One hundred and twenty-one consecutive patients with ANCA-associated glomerulonephritis, diagnosed in the Institute of Nephrology, Peking University First Hospital from 1997 to 2010, were analyzed retrospectively. Renal biopsy was performed at the time of diagnosis. All patients met the criteria of the Chapel Hill Consensus Conference definition for AAV [8] . Patients with secondary vasculitis or with comorbid renal diseases, such as anti-glomerular basement membrane nephritis, IgA nephropathy, diabetic nephropathy, lupus nephritis or membranous glomerulonephropathy, were excluded.
Renal histopathology and classification of renal biopsies
Renal specimens were evaluated using direct immunofluorescence (for immunoglobulins and complement components), light and electron microscopy. For light microscopy, periodic acid-Schiff together with silver methenamine, hematoxylin and eosin and Masson's trichrome staining were used. Biopsies were independently scored by two pathologists, blinded to the clinical data, according to the previously standardized definitions. Differences in scoring between the two pathologists were resolved by re-reviewing the biopsies and coming to consensus.
The standardized definitions of the glomerular lesions were as follows, as described previously by Berden et al. [6] . (i) Normal glomeruli referred to glomeruli without vasculitic lesions or global sclerosis. Normal glomeruli might show subtle changes as a result of ischemia or a minimum number of inflammatory cells (fewer than four neutrophils, lymphocytes or monocytes per glomeruli). (ii) Cellular crescents referred to cellular components of the crescent for 10%, irrespective of whether it was segmental or circumferential or whether it contained other components such as fibrin or was accompanied by a periglomerular granulomatous reaction or by breaking of Bowman's capsule. (iii) Fibrous crescents referred to extracellular matrix of the crescent for 90%. (iv) Global glomerulosclerosis referred to sclerotic changes in the glomerular tuft for 80%. The classification system composed of four categories was defined as described previously [6] . The focal category was defined as !50% normal glomeruli; the crescentic category was defined as the presence of !50% of glomeruli with cellular crescents; the mixed category involved biopsies in which a combination of normal, crescentic and sclerotic glomeruli were present, all occurring in <50% of glomeruli; the sclerotic category included biopsies characterized by !50% globally sclerotic glomeruli [6] . A minimum of 10 glomeruli were considered adequate to classify the specimen [9] . All the biopsies were performed before the initiation of immunosuppressive therapy.
Interstitial and tubular lesions were scored semiquantitatively, as described previously [1, 2, 4] , on the basis of the percentage of the tubulointerstitial compartment that was affected: tubular atrophy ('À' for 0%, '1' for 0-50%, '11' for >50%), interstitial infiltrates ('À' for 0%, '1' for 0-20%, '11' for 20-50% and '111' for >50%) and interstitial fibrosis ('À' for 0%, '1' for 0-50%, '11' for >50%). The interstitial and tubular lesions were scored manually.
Detection of ANCA
ANCA tests were performed by both indirect immunofluorescence assay and antigen-specific ELISA for all patients at the time of presentation and before immunosuppressive treatment was instituted. Standard IIF assay was performed according to the manufacturer (EUROIMMUN, Lübeck, Germany). In antigen-specific ELISA, two ANCA antigens, proteinase-3 (PR3) and myeloperoxidase (MPO), highly purified as previously reported [10] , were used in solid-phase assays.
Treatment
Treatment protocols have been described previously [11, 12] . The induction therapy included corticosteroids in combination with cyclophosphamide (CTX). Oral prednisone was prescribed at an initial dosage of 1 mg/ kg/day for 4-6 weeks, with reducing doses over time to 12.5-15 mg by 3 months. CTX was started 10-14 days following institution of corticosteroids, daily oral 2 mg/kg/day or intravenous 0.5-1.0 g/m 2 every month. Twenty-five percent dose reduction of CTX was made for those over 65 years old, those who developed leukocytopenia (<4 000 cells/mm 3 ) or those with renal insufficiency. Patients with acute renal failure or pulmonary hemorrhage received 3 pulses of intravenous methylprednisolone (7-15 mg/kg/day) before the above standard induction therapy. Patients with severe pulmonary hemorrhage additionally received plasma exchanges. For maintenance therapy, intravenous CTX every 3 months or daily oral azathioprine (AZA) was given.
Renal response to treatment
Renal response to treatment at 6 months after initiation of immunosuppressive therapy was judged according to the following criteria: (i) complete recovery of renal function was indicated by normalization of renal function and resolution of hematuria; (ii) partial recovery of renal function was indicated by stabilization or improvement of renal function, with serum creatinine !133 lmol/L but dialysis independent; (iii) treatment failure was indicated by progressive decline in kidney function with persistence of active urinary sediment despite immunosuppressive therapy [13] [14] [15] .
Statistical analysis
Chi-square, one-way analysis of variance and t-test were performed when appropriate. Kaplan-Meier survival analysis was used to assess renal survival as well as patient survival. Multivariate analysis of survival was performed by Cox regression model. Results were expressed as hazard ratio (HR) with 95% confidence intervals (CI). The following variables were assessed as potential predictors of renal response to treatment as well as end-stage renal disease (ESRD): age, gender, ANCA specificities, initial serum creatinine and histological categories. A P-value <0.05 was considered significant. Analysis was performed with the SPSS statistical software package (version 11.0; Chicago, IL).
Results
Demographic and clinical data
Among the 121 patients with ANCA-associated glomerulonephritis, 64 were male and 57 were female, with an average age of 57.2 AE 14.7 (range 15-81) years at the time of renal biopsy. According to the Chapel Hill Consensus Conference definitions [7] , 49/121 (40.5%) patients were classified as GPA 68/121 (56.2%) as MPA and 4/121 (3.3%) as RLV. Hundred and eight of 121 (89.3%) patients were positive for perinuclear ANCA (pANCA) and all those sera recognized MPO in antigen-specific ELISA. Thirteen of 121 (10.7%) patients were positive for cytoplasmic ANCA (cANCA) and all those sera recognized PR3 in antigen-specific ELISA (Table 1) . So, a significant number of patients with GPA were MPO-ANCA positive. This was consistent with our previous findings and might be a feature of GPA in Chinese patients [16] [17] [18] . Estimated glomerular filtration rate was calculated as previously described [19] .
For induction of remission, 26/121 (21.5%) patients received daily oral CTX, 95/121 (78.5%) patients received monthly intravenous CTX. Six of 121 patients (5.0%) received plasma exchange. Among the 85 patients who Table 2 . Typical examples of glomerular lesions are shown in Figure 1 .
Categories of the renal biopsies
The classification flowchart of the 121 patients is shown in Figure 2 .
An average number of 25.7 AE 10.4 glomeruli could be evaluated per renal biopsy specimen. According to the proposed classification described above, 11/121 (9.1%) biopsies were classified as sclerotic ANCA-associated glomerulonephritis. The proportions of globally sclerotic glomeruli, normal glomeruli, glomeruli with cellular crescents and glomeruli with fibrous crescents in these specimens were 62. 
Association between histopathologic categories and clinical parameters as well as survival
There were significant differences in urinary protein levels among patients with focal, mixed, crescentic and sclerotic categories (1.42 AE 1.41 g/24 h, 1.85 AE 1.05 g/24 h, 2.18 AE 1.57 g/24 h, 3.02 AE 1.94 g/24 h, P < 0.05). The prevalence of nephrotic syndrome was significantly lower in patients with the focal and mixed categories than in patients with the sclerotic category (6.1 versus 36.4%, P < 0.05; 0 versus 36.4%, P < 0.05, respectively) ( Table 2 ).
Significant differences were observed in the initial serum creatinine among patients with focal, mixed, crescentic and sclerotic categories (195.9 AE 168.4 lmol/L, 340.8 AE 237.6 lmol/L, 442.9 AE 241.0 lmol/L and 752.0 AE 302.7 lmol/L, respectively, P < 0.001) (Figure 3) .
Six months after initiation of the induction therapy described above, 36/121 (29.8%) patients achieved complete recovery of renal function, 66/121 (54.5%) patients achieved partial recovery of renal function and 19/121 (15.7%) patients had treatment failure. Significant differences were noted in the renal responses to treatment among the four groups of patients (P < 0.01, Table 3 ). However, in Figure 4 . The probability of developing ESRD increased with the ascending category of focal, mixed, crescentic and sclerotic glomerulonephritis (P < 0.01). The cumulative proportion of renal survival at 1 year was 100, 82.5, 72.7 and 29.4% for the focal, mixed, crescentic and sclerotic categories, respectively (P < 0.01). The cumulative proportions of renal survival at 2 years were 92.9, 71.5, 60.0 and 29.4% for the focal, mixed, crescentic and sclerotic categories, respectively (P < 0.01).
Besides the histological categories, variables including age, gender, ANCA specificities and initial serum creatinine were assessed as potential predictors of ESRD in the COX regression analysis (Table 4) . After adjusting for age, gender, ANCA specificities and initial serum creatinine, there were still significant differences in renal survival among the four groups of patients (P ¼ 0.022). Patients with focal, mixed and crescentic ANCA-associated glomerulonephritis were all at decreased risk for developing ESRD compared with those with sclerotic ANCA-associated glomerulonephritis (P < 0.05, HR 0.103, 95% CI 0.021-0.510; P < 0.05, HR 0.178, 95% CI 0.043-0.732 and P < 0.05, HR 0.260, 95% CI 0.089-0.760, respectively).
There was no significant difference in patient survival among the four groups ( Figure 5 ).
Tubulointerstitial lesions
Among the 121 patients, 114/121 (94.2%) had tubular atrophy. Forty-two of 114 (36.8%) were scored (1) and 72/114 (63.2%) were scored (11), respectively. Interstitial infiltrates could be seen in 114/121 (94.2%) patients. Thirtyeight of 114 (33.3%), 60/114 (52.6%) and 16/114 (14.1%) were scored (1), (11) and (111), respectively. Eightyone of 121 (66.9%) had interstitial fibrosis. Thirty-eight of 81 (46.9%) were scored (1) and 43/81 (53.1%) were scored (11), respectively.
When the above three forms of tubulointerstitial lesions were also included in the multivariate analysis as potential predictors of ESRD, none of them was an independent predictor of ESRD. 
Discussion
Involvement of the kidney is one of the most common and potentially life-threatening manifestations of AAV.
The recently published histopathologic classification of ANCA-associated glomerulonephritis could be useful for the prognostication of patients at the time of diagnosis [6] . In order to re-evaluate this new classification, 121 patients with ANCA-associated glomerulonephritis, diagnosed in a single center, were analyzed in the current study.
The histopathologic categories correlated with the initial serum creatinine, suggesting that this classification system reflects the severity of the initial renal function. The classification system was also associated with the renal response to treatment.
The probability of progressing to ESRD increased with the ascending category of focal, mixed, crescentic and sclerotic glomerulonephritis. More importantly, after adjusting for such parameters as age, gender, ANCA specificities and initial serum creatinine, the histopathologic category could still predict ESRD.
In our study, the probability of progressing to ESRD increased with the ascending sequence of focal, mixed, crescentic and sclerotic glomerulonephritis. This differed from the sequence in the study of Berden et al. [6] , in which the probability of progressing to ESRD increased from focal to crescentic, mixed and sclerotic glomerulonephritis. We speculate that this difference is attributed to the following reasons. Firstly, in our cohort, patients with crescentic ANCA-associated glomerulonephritis had more chronic lesions and, therefore, responded to the immunosuppressive therapy less satisfactorily. In Chinese patients with AAV, MPO-ANCA was much more common than PR3-ANCA [11,16-18, Re-evaluation of histopathologic classification of ANCA-GN 2347 20, 21] . The proportion of patients with MPO-ANCA was significantly higher in our cohort than that in Berden's cohort (108/121 versus 47/100, P < 0.01). Chronic lesions are more abundant in patients with MPO-ANCA than in patients with PR3-ANCA [4] . However, since there were only 13 patients with PR3-ANCA in our cohort, it was not possible to further analyze renal outcome of the four histological categories in this small sub-group of patients and to compare these with the outcome of their MPO-ANCA-positive counterparts. Secondly, plasma exchange has proven in the MEPEX study to be more effective for renal recovery than methylprednisolone pulse therapy in AAV patients with severe acute renal failure [22] . In our cohort, only a minority of patients with crescentic ANCA-associated glomerulonephritis received plasma exchange. This was especially the case before 2007 when the MEPEX study was published [22] . In fact, only four of the 53 patients with crescentic ANCA-associated glomerulonephritis received plasma exchanges. On the contrary, Berden's cohort included patients who participated in the MEPEX study [22] . This sub-group of patients was the main source of crescentic category in Berden's study. About half of the patients who were recruited in the MEPEX study received plasma exchange. Therefore, they could have had a better renal recovery than the patients in our cohort. Thirdly, the dose of CTX used in our study was lower than that used in the European Vasculitis Study Group study [22] . Lastly, patients with mixed ANCA-associated glomerulonephritis in our cohort had milder lesions than those in Berden's cohort. In this sub-group of patients, the proportion of globally sclerotic glomeruli and fibrous crescents was lower in our cohort than that in Berden's cohort (22.1 versus 27% and 11.7 versus 15%); the proportion of normal glomeruli in our cohort was higher than that in Berden's cohort (26.4 versus 21%).
The current study found that tubulointerstitial lesions were not independent predictors of ESRD, which is consistent with the study of Berden et al. [6] .
In conclusion, the proposed classification system was reevaluated in a relative large and independent series for the first time. This system could reflect the severity of the initial renal function impairment and predict, at least to some extent, the renal response to treatment. More importantly, it could independently predict ESRD. As it was a retrospective study, conformation in a prospective is warranted.
